Serenus Global
  • Home
  • Divisions
    • Psychedelics Division
    • Cannabis Division
  • Why Serenus
  • Shop
  • News
  • Contact Us
  • Investors
    • Investor Overview
    • Press Releases
    • Latest Presentation
    • Management Team
    • Corporate Charters
  • News
  • Shop
  • Contact Us
Select Page
RFK Jr. Pledges To Legalize Marijuana And Psychedelics, Using Revenue To Fund Farms Where People Recovering From Drug Addiction Can Grow Organic Food

RFK Jr. Pledges To Legalize Marijuana And Psychedelics, Using Revenue To Fund Farms Where People Recovering From Drug Addiction Can Grow Organic Food

Jun 29, 2023 | Psychedelics

RFK Jr. Pledges To Legalize Marijuana And Psychedelics, Using Revenue To Fund Farms Where People Recovering From Drug Addiction Can Grow Organic Food Robert F. Kennedy Jr., a 2024 Democratic presidential candidate, says that he would legalize marijuana and...
California Assembly Committee Approves Senate-Passed Psychedelics Legalization Bill

California Assembly Committee Approves Senate-Passed Psychedelics Legalization Bill

Jun 27, 2023 | Psychedelics

California Assembly Committee Approves Senate-Passed Psychedelics Legalization Bill A California Assembly committee has approved a Senate-passed bill to legalize the possession and facilitated use of certain psychedelics. The Assembly Public Safety Committee advanced...
FDA discloses its first draft guidance on psychedelic trials

FDA discloses its first draft guidance on psychedelic trials

Jun 26, 2023 | Psychedelics

FDA discloses its first draft guidance on psychedelic trials The US Food and Drug Administration (FDA) has released its first draft guidance on clinical trials investigating psychedelic drugs. The agency aims to provide fundamental considerations for researchers...
Three In Five American Voters Support Legalizing Psychedelic Therapy, And Half Want To End Criminalization Altogether, New Poll Finds

Three In Five American Voters Support Legalizing Psychedelic Therapy, And Half Want To End Criminalization Altogether, New Poll Finds

Jun 26, 2023 | Psychedelics

Three In Five American Voters Support Legalizing Psychedelic Therapy, And Half Want To End Criminalization Altogether, New Poll Finds About three in five American voters say psychedelics should be legalized for regulated, therapeutic use—and nearly half believe...
Mindset Pharma Receives Approval for Phase II Depression Trial

Mindset Pharma Receives Approval for Phase II Depression Trial

Jun 23, 2023 | Psychedelics

Mindset Pharma Receives Approval for Phase II Depression Trial Mindset Pharma has been granted approval to start a Phase 2 trial for Major Depressive Disorder, using their lead drug candidate MSP-1014 MSP-1014 is a novel prodrug of psilocin, the active metabolite of...
FDA Releases First-Ever Draft Guidance For Psychedelics Research, Days After Congressional Lawmakers File Bill Asking For It

FDA Releases First-Ever Draft Guidance For Psychedelics Research, Days After Congressional Lawmakers File Bill Asking For It

Jun 23, 2023 | Psychedelics

FDA Releases First-Ever Draft Guidance For Psychedelics Research, Days After Congressional Lawmakers File Bill Asking For It The Food and Drug Administration (FDA) has released first-of-its-kind draft guidance on the “unique” considerations that researchers should...
« Older Entries
Next Entries »
Email Alerts Shop Products

NEWSLETTER SIGNUP

NEWS

  • Company News
  • Industry News
  • Email Alerts

DIVISIONS

  • Psychedelics
  • Cannabis

INVESTORS

  • Press Releases
  • Latest Presentation
  • Board of Directors
  • Corporate Charters

COMPANY

  • Why Serenus
  • Management Team
  • Contact Us
  • FAQ’s
  • Facebook
  • Twitter
  • Instagram
© Copyright 2023 Serenus Global. All rights reserved.
Privacy PolicyTerms and Conditions